Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
Clinical trial NCT04401579 · COMPLETED
Trial details
- NCT number
- NCT04401579
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-07-31
- Enrollment
- 1033
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.